INTERNATIONAL PATENT: SYNNOVATION THERAPEUTICS, INC. FILES APPLICATION FOR "5-OXO-4,5-DIHYDROIMIDAZO[1,5-A]QUINAZOLINE COMPOUNDS AS PI3K[ALPHA] INHIBITORS"

GENEVA, April 30 -- SYNNOVATION THERAPEUTICS, INC. (200 Powder Mill Road E500-1801Wilmington, Delaware 19803) filed a patent application (PCT/US2024/051504) for "5-OXO-4,5-DIHYDROIMIDAZO[1,5-A]QUINAZOLINE COMPOUNDS AS PI3K[ALPHA] INHIBITORS" on Oct 16, 2024. With publication no. WO/2025/085474, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QI, Chao (c/o Synnovation Therapeutics, Inc.200 Powder Mill Road E500-1801Wilmington, Delaware 19803), ZHOU, Fei (c/o Synnovation Therapeutics, Inc.200 Powder Mill Road E500-1801Wilmi...